52 related articles for article (PubMed ID: 1732442)
1. Detection of abnormal cardiac adrenergic neuron activity in adriamycin-induced cardiomyopathy with iodine-125-metaiodobenzylguanidine.
Wakasugi S; Wada A; Hasegawa Y; Nakano S; Shibata N
J Nucl Med; 1992 Feb; 33(2):208-14. PubMed ID: 1732442
[TBL] [Abstract][Full Text] [Related]
2. Iodine 123-labeled metaiodobenzylguanidine imaging in heart disease.
Merlet P; Valette H; Dubois-Randé JL; Mardon K; Pouillart F; Bourachot ML; Castaigne A; Syrota A
J Nucl Cardiol; 1994; 1(2 Pt 2):S79-85. PubMed ID: 9420702
[TBL] [Abstract][Full Text] [Related]
3. Heart Transplantation for Adriamycin Cardiomyopathy: The Plural of Anecdote and the Power of Registries.
Kittleson MM
JACC CardioOncol; 2021 Jun; 3(2):302-304. PubMed ID: 34396338
[TBL] [Abstract][Full Text] [Related]
4. Anthracycline-induced cardiotoxicity: From pathobiology to identification of molecular targets for nuclear imaging.
Jong J; Pinney JR; Packard RRS
Front Cardiovasc Med; 2022; 9():919719. PubMed ID: 35990941
[TBL] [Abstract][Full Text] [Related]
5. MIBG cardiac imaging compared to ejection fraction in evaluation of cardiotoxicity: a systematic review.
Arrais TR; Cavalli GD; Dos Santos BT; Pereira GB; Migliavaca CB; Grossman GB; Biolo A
J Nucl Cardiol; 2022 Oct; 29(5):2274-2291. PubMed ID: 34228328
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular imaging in cardio-oncology.
Mahabadi AA; Rischpler C
J Thorac Dis; 2018 Dec; 10(Suppl 35):S4351-S4366. PubMed ID: 30701103
[TBL] [Abstract][Full Text] [Related]
7. Whole Body PET Imaging with a Norepinephrine Transporter Probe 4-[
Lokitz SJ; Garg S; Nazih R; Garg PK
Mol Imaging Biol; 2019 Aug; 21(4):686-695. PubMed ID: 30250991
[TBL] [Abstract][Full Text] [Related]
8. How do we establish cardiac sympathetic nervous system imaging with
Travin MI; Matsunari I; Thomas GS; Nakajima K; Yoshinaga K
J Nucl Cardiol; 2019 Aug; 26(4):1434-1451. PubMed ID: 30178272
[TBL] [Abstract][Full Text] [Related]
9. From Molecular Mechanisms to Clinical Management of Antineoplastic Drug-Induced Cardiovascular Toxicity: A Translational Overview.
Tocchetti CG; Cadeddu C; Di Lisi D; Femminò S; Madonna R; Mele D; Monte I; Novo G; Penna C; Pepe A; Spallarossa P; Varricchi G; Zito C; Pagliaro P; Mercuro G
Antioxid Redox Signal; 2019 Jun; 30(18):2110-2153. PubMed ID: 28398124
[No Abstract] [Full Text] [Related]
10. Anthracycline-induced cardiomyopathy: The search continues.
Kim AS; Bergmann SR
J Nucl Cardiol; 2017 Feb; 24(1):265-267. PubMed ID: 26645603
[No Abstract] [Full Text] [Related]
11. Recent Advances on Pathophysiology, Diagnostic and Therapeutic Insights in Cardiac Dysfunction Induced by Antineoplastic Drugs.
Molinaro M; Ameri P; Marone G; Petretta M; Abete P; Di Lisa F; De Placido S; Bonaduce D; Tocchetti CG
Biomed Res Int; 2015; 2015():138148. PubMed ID: 26583088
[TBL] [Abstract][Full Text] [Related]
12. Autonomic dysfunction in early breast cancer: Incidence, clinical importance, and underlying mechanisms.
Lakoski SG; Jones LW; Krone RJ; Stein PK; Scott JM
Am Heart J; 2015 Aug; 170(2):231-41. PubMed ID: 26299219
[TBL] [Abstract][Full Text] [Related]
13. Radionuclide imaging of cardiac sympathetic innervation in heart failure: unlocking untapped potential.
Gupta S; Amanullah A
Heart Fail Rev; 2015 Mar; 20(2):215-26. PubMed ID: 25135163
[TBL] [Abstract][Full Text] [Related]
14. Cardiotoxicity of antineoplastic agents: what is the present and future role for imaging?
Markman TM; Markman M
Curr Oncol Rep; 2014; 16(8):396. PubMed ID: 24992733
[TBL] [Abstract][Full Text] [Related]
15. Alterations of pre- and postsynaptic noradrenergic signaling in a rat model of adriamycin-induced cardiotoxicity.
Kenk M; Thackeray JT; Thorn SL; Dhami K; Chow BJ; Ascah KJ; DaSilva JN; Beanlands RS
J Nucl Cardiol; 2010 Apr; 17(2):254-63. PubMed ID: 20182926
[TBL] [Abstract][Full Text] [Related]
16. The echocardiographic Tei-index reflects early myocardial damage induced by anthracyclines in patients with hematological malignancies.
Senju N; Ikeda S; Koga S; Miyahara Y; Tsukasaki K; Tomonaga M; Kohno S
Heart Vessels; 2007 Nov; 22(6):393-7. PubMed ID: 18043997
[TBL] [Abstract][Full Text] [Related]
17. Monitoring chemotherapy-induced cardiotoxicity: role of cardiac nuclear imaging.
Panjrath GS; Jain D
J Nucl Cardiol; 2006; 13(3):415-26. PubMed ID: 16750786
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of cardiac (123)I metaiodobenzylguanidine imaging for mortality and morbidity in patients with chronic heart failure: a prospective study.
Ogita H; Shimonagata T; Fukunami M; Kumagai K; Yamada T; Asano Y; Hirata A; Asai M; Kusuoka H; Hori M; Hoki N
Heart; 2001 Dec; 86(6):656-60. PubMed ID: 11711461
[TBL] [Abstract][Full Text] [Related]
19. 123I-MIBG myocardial scintigraphy as a noninvasive screen for the diagnosis of coronary artery spasm.
Ha JW; Lee JD; Jang Y; Chung N; Kwan J; Rim SJ; Lee YJ; Shim WH; Cho SY; Kim SS
J Nucl Cardiol; 1998; 5(6):591-7. PubMed ID: 9869481
[TBL] [Abstract][Full Text] [Related]
20. Myocardial iodine-labeled metaiodobenzylguanidine 123 uptake relates to age.
Estorch M; Carrió I; Berná L; López-Pousa J; Torres G
J Nucl Cardiol; 1995; 2(2 Pt 1):126-32. PubMed ID: 9420777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
